HX008 Plus Chemotherapy VS Pembrolizumab Plus Chemotherapy As the First-line Treatment in Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer
Clinical trial NCT04750083 · UNKNOWN
Trial details
- NCT number
- NCT04750083
- Sponsor
- Taizhou Hanzhong biomedical co. LTD
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-25
- Primary completion
- 2022-09-25
- Enrollment
- 700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.